-
New 'how-to guide' for future rapid vaccine development
Until recently, human vaccine development has typically taken 10 to 15 years.... Read more -
Offering HPV vaccination to people past their mid-20s is unlikely to be cost-effective
A modeling study projected that HPV vaccination programs for adults aged 27 to 45 years could benefit subgroups at higher... Read more -
Studies examine cost-effectiveness of maternal RSV vaccination and nirsevimab in infants
Seasonal maternal respiratory syncytial virus (RSV) vaccination and nirsevimab for infants demonstrate cost-effectiveness, according to two studies published online Nov.... Read more -
New malaria vaccine shows high protection in clinical trial
Researchers at Leiden University Medical Center and Radboud University Medical Center in the Netherlands have demonstrated promising safety and efficacy... Read more
-
Flu, COVID vaccination rates remain low as winter nears
Worn down by pandemic-era vaccine overload, many Americans are ignoring pleas by health officials to get immunized against the flu... Read more -
Malaria ravages Nigerian city infamous for vaccine doubts
Zuwaira Muhammad sat beside her emaciated 10-month-old twins on a clinic bed in northern Nigeria, caring for them as they... Read more
-
The UK is no longer offering COVID vaccines to pregnant women. Here's why that might be a bad idea
Until now, COVID vaccines have been available to pregnant women as part of the twice-yearly booster program, but this offer... Read more -
UN authorizes first mpox vaccine for children in an attempt to control Congo outbreak
The World Health Organization has authorized the first mpox vaccine for children, a decision experts hope will help make immunizations... Read more -
Preventing severe malaria by harnessing natural human antibodies
Malaria, particularly in its severe forms, remains a global health and economic burden. It causes the deaths of more than... Read more -
WHO approves second mpox vaccine
The World Health Organization on Tuesday approved an mpox vaccine from Japanese pharma company KM Biologics for emergency use, the... Read more -
Pakistan reports new polio case in northwest, raising nationwide tally to 50 cases this year
Pakistan detected one more polio case in the restive northwest bordering Afghanistan, raising the country's tally of the infectious disease... Read more -
Scientists analyze virus protein structure to advance RSV vaccines
In most people, the lung-infecting pathogens known as respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) trigger mild cold-like symptoms.... Read more -
The reality of RSV: Doctor explains who should get vaccinated
Respiratory syncytial virus, or RSV, is something many parents know as a cause of bronchiolitis, but others may not have... Read more -
New nasal vaccine shows promise in curbing whooping cough spread
As whooping cough cases rise in the U.S., a new nasal vaccine developed by Tulane University may hold the key... Read more -
Walking pneumonia, whooping cough surge in San Diego County
San Diego County's public health department warned local doctors Friday that the region is in the midst of a significant... Read more
